| OSE IMMUNOTHERAPE.EO -,20 |
| Frankreich |
| Gesundheit |
| FR0012127173 / A14QXP |
| 6OP (Frankfurt) |
| FRA:6OP, ETR:6OP, 6OP:GR |
| - |
| https://ose-immuno.com/ |
|
OSE Immunotherapeutics SA is a clinical-stage biotechnology company based in Nantes and Paris, France, specializing in the development of first-in-class immunotherapies for immuno-oncology and immuno-inflammation. The company focuses on innovative as..
>Volltext.. |
| 68.39 Mio. EUR |
| 65.48 Mio. EUR |
| 2.19 Mio. EUR |
| -42.11 Mio. EUR |
| -35.48 Mio. EUR |
| -1.61 EUR |
| 39.38 Mio. EUR |
| 25.86 Mio. EUR |
| -37.32 Mio. EUR |
| 2.14 |
| -96.92% |
| -175.68% |
| - |
| - |
| - |
| - |
| OSE IMMUNOTHERAPEUTICS, OSE IMMUNO |
| 01.04.26 |
|